Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CASPER-Pilot: Early vs Late Adjunctive Vasopressin in Septic Shock
NCT06709573Phase 4Recruiting
- Sponsor
- Cleveland Clinic
- Start
- Apr 2025
- Primary completion
- May 2027
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of vasopressin in septic shock, sponsored by Cleveland Clinic. Started Apr 2025; status: recruiting.
02
Drugs
vasopressin
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT06709573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06709573.